A U.S. study suggests that Laotian and Hmong Americans with liver cancer are usually diagnosed at an advanced stage and are also more than twice as likely to die from the disease compared with other groups of Asian descent. Only 3% of patients from the two groups were treated with surgery or liver transplantation for the disease, compared with 22% of other Asians, researchers reported.

Related Summaries